Temporal order of diagnosis between gambling disorder and substance use disorders: Longitudinal results from the Norwegian Patient Registry

Girard, Lisa-Christine; Griffiths, Mark D.; Rossow, Ingeborg; Leino, Tony; Goudriaan, Anna E.; Smith, Otto Robert Frans; Pallesen, Ståle

doi:10.1016/j.abrep.2023.100501

Cited by 2 publications

(1 citation statement)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Still, important categories such as ICD 10 codes stimulants have been associated with good accuracy for classifying methamphetamine use. 41 Compared with other studies using ICD codes to identify SU mortality, we have used a broader definition with more inclusive ICD codes to capture more patients with a history of SU, 42 although we could not independently verify the accuracy of these codes for SU. Using ICD codes, we were not able to specifically identify or differentiate users of alternative form of the substances (for instance, patients who used cannabis extracts).…”

Section: Discussionmentioning

confidence: 99%

Temporal Trends in Substance Use and Cardiovascular Disease–Related Mortality in the United States

Minhas,

Kewcharoen,

Hall

et al. 2024

JAHA

View full text Add to dashboard Cite

Background There are limited data on substance use (SU) and cardiovascular disease (CVD)–related mortality trends in the United States. We aimed to evaluate SU+CVD–related deaths in the United States using the Centers for Disease Control and Prevention Wide‐Ranging, Online Data for Epidemiologic Research database. Methods and Results The Multiple Cause‐of‐Death Public Use record death certificates were used to identify deaths related to both SU and CVD. Crude, age‐adjusted mortality rates, annual percent change, and average annual percent changes with a 95% CI were analyzed. Between 1999 and 2019, there were 636 572 SU+CVD‐related deaths (75.6% men, 70.6% non‐Hispanic White individuals, 65% related to alcohol). Age‐adjusted mortality rates per 100 000 population were pronounced in men (22.5 [95% CI, 22.6–22.6]), American Indian or Alaska Native individuals (37.7 [95% CI, 37.0–38.4]), nonmetropolitan/rural areas (15.2 [95% CI, 15.1–15.3]), and alcohol‐related death (9.09 [95% CI, 9.07 to 9.12]). The overall SU+CVD‐related age‐adjusted mortality rates increased from 9.9 (95% CI, 9.8–10.1) in 1999 to 21.4 (95% CI, 21.2–21.6) in 2019 with an average annual percent change of 4.0 (95% CI, 3.7–4.3). Increases in SU+CVD‐related average annual percent change were noted across all subgroups and were pronounced among women (4.8% [95% CI, 4.5–5.1]), American Indian or Alaska Native individuals, younger individuals, nonmetropolitan areas, and cannabis and psychostimulant users. Conclusions There was a prominent increase in SU+CVD‐related mortality in the United States between 1999 and 2019. Women, non‐Hispanic American Indian or Alaska Native individuals, younger individuals, nonmetropolitan area residents, and users of cannabis and psychostimulants had pronounced increases in SU+CVD mortality.

show abstract

Section: Discussionmentioning

confidence: 99%